|
Index of reports
> Cases with Acute Myeloid Leukaemia (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include acute myeloid leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-02
Patient: 50 year old female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: received eight courses.
Docetaxel
Dosage: eight courses.
Epirubicin
Dosage: received eight courses.
Therapeutic Radiopharmaceuticals
Dosage: received 50 gy of irradiation to conserved breast and supraclavicular fossa
Possible Epirubicin side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-13
Patient: 67 year old female
Reactions: Acute Myeloid Leukaemia, Pyrexia, Papule
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Docetaxel
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Epirubicin
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Fluorouracil
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Idarubicin HCL
Dosage: (12 mg/m2)
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: (7 mg/m2)
Indication: Acute Myeloid Leukaemia
Tegafur Uracil (Tegafur / Uracil)
Dosage: (df oral)
Administration route: Oral
Indication: Colon Cancer
Trastuzumab (Trastuzumab)
Dosage: (1 df 3x/week)
Indication: Breast Cancer
Possible Epirubicin side effects in 66 year old female
Reported by a individual with unspecified qualification from Japan on 2012-04-10
Patient: 66 year old female
Reactions: Acute Myeloid Leukaemia, Pancytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Anastrozole
Indication: Breast Cancer
Start date: 2008-04-01
End date: 2008-10-01
Capecitabine
Start date: 2007-06-01
End date: 2007-09-01
Capecitabine
Indication: Breast Cancer
Start date: 2007-03-01
End date: 2007-05-01
Cyclophosphamide
Indication: Breast Cancer
Start date: 2006-08-01
End date: 2007-02-01
Cyclophosphamide
Start date: 2007-03-01
End date: 2007-05-01
Epirubicin
Indication: Breast Cancer
Start date: 2006-08-01
End date: 2007-02-01
Fluorouracil
Indication: Breast Cancer
Start date: 2006-08-01
End date: 2007-02-01
Letrozole
Indication: Breast Cancer
Start date: 2007-02-01
Taxotere
Indication: Breast Cancer
Start date: 2006-08-01
Taxotere
Start date: 2006-11-09
End date: 2007-01-11
Toremifene
Start date: 2007-10-01
End date: 2008-03-01
Toremifene
Indication: Breast Cancer
Start date: 2007-06-01
End date: 2007-09-01
TS-1
Indication: Breast Cancer Metastatic
Start date: 2008-10-01
End date: 2011-06-01
Possible Epirubicin side effects in 50 year old
Reported by a physician from Turkey on 2012-03-14
Patient: 50 year old
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Docetaxel
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Therapeutic Radiopharmaceuticals
Indication: Breast Cancer
Possible Epirubicin side effects in
Reported by a physician from Turkey on 2012-03-13
Patient:
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: not reported
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Dosage: not reported
Indication: Breast Cancer
Paclitaxel
Dosage: not reported
Indication: Breast Cancer
Tamoxifen Citrate
Dosage: not reported
Indication: Breast Cancer
Therapeutic Radiopharmaceuticals
Dosage: not reported
Indication: Breast Cancer
Possible Epirubicin side effects in 45 year old
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-03-13
Patient: 45 year old
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Therapeutic Radiopharmaceuticals
Indication: Breast Cancer
Other drugs received by patient: Tamoxifen Citrate
Possible Epirubicin side effects in 66 year old female
Reported by a physician from Japan on 2012-01-04
Patient: 66 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: dosage is uncertain.
Start date: 2007-03-01
End date: 2007-05-01
Cyclophosphamide
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Start date: 2006-08-11
Epirubicin
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Start date: 2006-08-11
Xeloda
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-03-01
End date: 2007-05-01
Xeloda
Dosage: dosage is uncertain.
Administration route: Oral
Start date: 2007-06-01
End date: 2007-09-01
Other drugs received by patient: Docetaxel (AS Comparator); Toremifene; Fluorouracil; Femara; Toremifene; Calcium Lactate; Urso 250
Possible Epirubicin side effects in
Reported by a physician from Belgium on 2011-10-04
Patient:
Reactions: Neoplasm Malignant, Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Cyclophosphamide
Epirubicin
Fluorouracil
Letrozole
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-03-18
Other drugs received by patient: Lormetazepam; Calcium Carbonate; Vitamin D
|
